Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
73.21295
male
0
12
CHF
COPD/CHF/Cirrhosis
2
null
null
0
8,677
7,295.0273
5,172.71875
16
white
31.398438
56
0.636963
0.454956
1
0
0
no
null
null
dnr after sadm
2
61
10.798828
118
32
34.5
409.5
3.599609
2.299805
2.199707
136
7.519531
null
null
null
null
null
null
2.921875
1,087
1
55.17899
male
0
6
CHF
COPD/CHF/Cirrhosis
3
null
null
26
12,149
10,395.0312
9,911.95312
14
white
19.597656
34
0.845947
0.745972
1
0
0
no
0.95
0.95
no dnr
6
82
5.299805
69
28
35.69531
null
4.5
1.399902
1.599854
133
null
null
null
null
null
null
null
2.302734
296
1
77.31696
male
0
9
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
5,602
4,353.6445
4,600.14844
11
white
13.898438
32
0.872925
0.789917
1
1
0
no
null
null
dnr after sadm
1
67
7.799805
107
28
36.39844
432
4.399414
0.399963
0.899902
145
7.359375
null
null
null
null
null
null
3.679199
554
1
88.62695
male
0
15
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
26
14,022
9,969.0078
8,733.35938
16.333328
white
22.398438
44
0.55896
0.362976
1
0
0
no
0.3
0.027
dnr after sadm
2
62
6.599609
77
28
36.19531
146.65625
3.199707
0.299988
1.199951
136
7.359375
null
null
null
null
3
no(M2 and SIP pres)
3
202
1
65.23798
male
0
10
CHF
COPD/CHF/Cirrhosis
5
8
under $11k
0
5,633
4,668.2891
3,727.29883
7.5
white
24.296875
42
0.80896
0.690918
1
1
0
no
0.75
0.7
no dnr
10
110
7
59
28
35.69531
428.5625
3.399902
0.399963
2.099609
133
7.439453
null
null
null
1
0
no(M2 and SIP pres)
0
923
1
64.68994
male
0
5
Lung Cancer
Cancer
2
15
$25-$50k
0
2,750
2,121.5391
1,604.00977
9
white
10.798828
15
0.812988
0.598999
1
0
0
metastatic
null
null
no dnr
5
100
5.099609
74
20
36.39844
null
3.799805
0.399963
1.199951
136
null
null
null
null
0
0
no(M2 and SIP pres)
0
201
1
69.78198
male
0
12
Lung Cancer
Cancer
2
9
$11-$25k
0
6,459
5,058.5156
4,221.13672
7
white
6.299805
31
0.859985
0.687988
1
0
0
metastatic
0.99
0.99
no dnr
12
108
3.699707
120
20
36.89844
null
4.699219
0.399963
1.299805
137
null
null
null
null
1
0
no(M2 and SIP pres)
0
447
1
71.27197
male
0
18
COPD
COPD/CHF/Cirrhosis
2
null
null
0
13,300
10,862.1719
9,594.3125
6.333332
white
15.798828
42
0.878906
0.79895
1
0
0
no
0.3
0.1
dnr after sadm
7
120
11.199219
112
28
35.89844
256
4.599609
0.5
1.299805
138
7.299805
null
null
null
null
null
<2 mo. follow-up
2.917481
20
1
72.29797
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
0
12,367
8,481.9609
8,367.04688
42.5
white
31.699219
54
0.629883
0.526978
1
0
0
no
null
null
dnr after sadm
7
77
16.5
130
36
38.59375
140
2.899902
0.799927
2.299805
137
7.459961
null
null
null
null
7
<2 mo. follow-up
7
9
1
76.25696
male
0
9
COPD
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
5,556
4,400.3125
4,423.92969
2.5
white
12.5
32
0.889893
0.815918
1
0
0
no
0.75
0.5
no dnr
9
100
4.899414
93
24
36.19531
185.6875
4.399414
0.399963
1.199951
140
7.389648
null
null
null
0
4
<2 mo. follow-up
4
44
1
66.97595
male
0
16
Lung Cancer
Cancer
2
12
$25-$50k
0
10,591
8,733.6641
7,617.78906
6.666664
white
8.699219
22
0.835938
0.640991
1
0
0
metastatic
0.9
0.75
no dnr
16
100
9.898438
77
20
35.79688
null
4.199219
0.299988
1.399902
137
null
null
null
null
5
null
no(M2 and SIP pres)
3.855299
709
1
47.60797
male
0
8
COPD
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
13,782
5,093.8789
6,117.56641
18.5
white
17
35
0.938965
0.896973
1
0
0
no
0.8
0.7
no dnr
8
80
7.399414
78
28
38.09375
133.3125
4.099609
2.199707
0.899902
137
7.30957
null
null
null
0
null
no(M2 and SIP pres)
0.4948
1,748
0
60.85699
female
0
10
COPD
COPD/CHF/Cirrhosis
0
12
$11-$25k
0
22,608
17,245.4531
17,407.9531
17.5
white
26.398438
42
0.759888
0.619995
8
0
0
no
0.9
0.3
no dnr
10
137
9.599609
62
14
36.19531
166.65625
3.799805
0.5
8.298828
128
7.349609
null
null
null
4
0
no(M2 and SIP pres)
0
76
1
64.50098
female
0
7
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
4,447
3,547.3477
3,210.31836
18
white
16.597656
17
0.893921
0.822998
1
1
0
no
0.5
0.4
no dnr
7
118
6.199219
79
20
36.89844
414.25
3
0.599976
1.299805
137
7.449219
null
null
null
1
null
null
1.1669
830
1
84.32898
male
0
6
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
3,099
2,538.4727
2,040.69922
8
white
16.597656
35
0.806885
0.68689
1
1
0
no
0.85
0.75
dnr after sadm
1
108
11.798828
74
24
36.09375
240
null
null
1.099854
136
7.469727
null
null
null
0
2
no(M2 and SIP pres)
2
667
1
72.745
male
0
7
CHF
COPD/CHF/Cirrhosis
4
null
null
0
4,613
3,877.4629
2,649.21875
12
white
16.296875
16
0.876953
0.795898
1
1
0
no
0.75
0.5
no dnr
7
86
null
60
24
36.19531
null
3.599609
0.699951
1.399902
139
null
null
null
null
null
null
null
2.160645
1,734
1
68.45697
male
0
5
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
4,895
3,740.168
3,707.04883
21
white
11.199219
31
0.922974
0.868896
1
0
0
no
0.9
0.7
no dnr
5
68
11.298828
82
24
35.5
280.9375
4.599609
0.699951
1.199951
136
7.459961
null
null
null
0
0
no(M2 and SIP pres)
0
1,744
0
78.00696
male
0
12
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
7,402
5,895.6055
5,017.9375
6.5
white
19.699219
35
0.800903
0.678955
1
1
0
no
null
null
no dnr
12
72
3.399902
102
28
35.79688
211.09375
3.699707
0.599976
1.299805
137
7.439453
null
null
null
0
1
no(M2 and SIP pres)
1
611
1
89.57397
female
0
9
CHF
COPD/CHF/Cirrhosis
2
12
null
9
11,755
8,758.7344
7,989.09766
23.5
white
24.199219
40
0.66394
0.48999
1
0
0
no
null
null
dnr after sadm
7
147
18.296875
122
42
36.09375
426.625
4.299805
0.399963
1.199951
127
7.40918
null
null
null
null
4
<2 mo. follow-up
4
11
1
50.50198
male
0
11
COPD
COPD/CHF/Cirrhosis
0
6
$11-$25k
0
20,682
13,876.9766
12,524.8359
18.5
white
19
21
0.921997
0.86792
1
0
0
no
null
null
no dnr
11
113
7.899414
67
30
36.19531
165.6875
3.699707
0.899902
1
138
7.40918
null
null
null
1
0
no(M2 and SIP pres)
0
1,744
0
73.02399
male
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
100
57,521
37,854.5625
38,666.25
48
white
37
64
0.015999
0.003
15
0
0
no
0.05
0.000125
dnr after sadm
1
70
20.597656
122
40
37.79688
148.96875
2.5
11.199219
1.899902
141
7.509766
null
null
null
null
null
<2 mo. follow-up
3.208984
10
1
60.991
male
0
17
COPD
COPD/CHF/Cirrhosis
2
11
null
0
23,869
16,551.0469
15,711.0078
27.333328
white
32.5
39
0.704956
0.543945
1
0
0
no
null
null
no dnr
17
117
11.798828
70
40
36.09375
133.3125
2.399902
1.599854
1.299805
139
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
1,736
0
71.72095
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
23,276
16,485.125
15,675.1172
26.5
hispanic
22.796875
50
0.80188
0.735962
1
1
0
no
0.99
0.99
no dnr
11
60
17.597656
103
28
36.59375
209.5
3.299805
1
1.5
137
7.40918
null
null
null
null
2
no(M2 and SIP pres)
2
1,734
0
19.21999
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
16,817
11,411.9375
11,381.5859
22
white
16.097656
14
0.950928
0.932983
2
0
0
no
0.99
0.99
no dnr
11
81
8.398438
66
42
38.79688
380
null
null
0.899902
135
7.419922
null
null
null
null
0
no(M2 and SIP pres)
0
1,734
0
78.57098
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
null
26
47,395
35,246.6875
30,058.875
16
white
24.597656
31
0.553955
0.440979
16
1
0
no
null
null
no dnr
16
101
12
72
26
36.29688
144.875
3.399902
1.699951
1.399902
140
7.479492
null
null
null
null
0
no(M2 and SIP pres)
0
1,661
1
65.84497
male
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$25-$50k
41
90,802
63,460.4688
55,595.1875
36.5
white
31.5
48
0.393982
0.274963
8
0
0
no
0.5
0.5
dnr after sadm
2
63
11.199219
127
10
39.29688
198
2.899902
3.899902
2.699707
135
7.389648
null
null
null
null
0
<2 mo. follow-up
0
27
1
62.70999
female
0
4
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,510
3,111.0527
2,587.94922
6
white
27.898438
44
0.763916
0.625977
1
1
0
no
0.97
0.5
no dnr
4
53
null
44
24
35.79688
null
null
null
1.799805
134
null
null
null
null
null
null
null
3.013672
194
1
77.00494
female
0
19
CHF
COPD/CHF/Cirrhosis
4
null
null
0
14,665
12,091.9844
9,107.26562
16.333328
white
28.5
54
0.678955
0.508911
1
1
0
no
null
null
no dnr
19
58
8.699219
124
44
35.39844
366.625
null
null
1.399902
132
7.449219
null
null
null
null
null
null
3.542481
408
1
52.92499
male
0
7
Colon Cancer
Cancer
1
12
$11-$25k
0
5,568
4,115.2227
3,993.5
15
white
18.199219
13
0.823975
0.61792
1
0
0
metastatic
0.7
0.1
no dnr
7
73
9.199219
62
20
36.89844
null
null
1.299805
0.799927
131
null
null
null
null
null
null
no(M2 and SIP pres)
1.758789
262
1
59.96997
male
0
8
Lung Cancer
Cancer
2
12
$25-$50k
0
10,149
7,605.6875
6,051.96875
8
white
21.898438
31
0.613892
0.297974
1
0
0
metastatic
0.8
0.8
no dnr
8
113
13
55
40
36.39844
371.375
null
null
1
133
7.469727
null
null
null
0
null
no(M2 and SIP pres)
0.4948
812
1
59.18399
male
0
5
Lung Cancer
Cancer
1
null
null
0
3,055
2,468.2969
1,996.10938
11
white
11.5
13
0.81189
0.596924
1
0
0
metastatic
null
null
no dnr
5
105
7.5
69
16
36.39844
null
3.799805
0.399963
0.799927
137
null
null
null
null
null
null
null
1.845459
366
1
65.53894
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
9
25,633
17,160.4375
16,895.9844
17.666656
white
27
36
0.687988
0.595947
4
0
0
no
0.9
0.9
no dnr
17
68
7.5
64
28
39.29688
54.53906
2.199707
0.799927
0.799927
134
7.449219
null
null
null
null
0
no(M2 and SIP pres)
0
1,728
0
81.79895
female
0
8
COPD
COPD/CHF/Cirrhosis
3
16
under $11k
0
7,246
5,610.4219
5,150.15625
6.5
white
19
34
0.785889
0.656982
1
0
0
no
0.9
0.7
no dnr
8
64
7.699219
98
28
36.09375
295.1875
null
0.299988
0.699951
142
7.469727
null
null
null
5
null
adl>=4 (>=5 if sur)
3.855299
1,720
0
58.42599
male
0
9
Lung Cancer
Cancer
2
null
null
0
2,853
2,602.0938
2,401.66992
5
white
7.699219
11
0.858887
0.685913
1
0
0
metastatic
0.7
0.3
no dnr
9
85
6.299805
83
20
36.69531
null
4
0.299988
1.199951
137
null
null
null
null
null
null
null
2.45752
65
1
75.72595
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
null
9
38,125
28,336.0469
24,094.9844
27.666656
white
28.097656
40
0.543945
0.429993
3
0
0
yes
0.3
0.5
dnr after sadm
14
67
5.299805
106
30
38
140
2.799805
4.5
1.099854
142
7.429688
null
null
null
null
2
<2 mo. follow-up
2
15
1
73.58197
male
0
11
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
9
27,783
19,685.6406
17,113.1094
26
white
26.898438
32
0.586914
0.394958
14
0
0
no
0.5
0.5
dnr after sadm
2
72
17.398438
119
44
38.79688
170
null
null
0.699951
142
7.429688
null
null
null
null
5
<2 mo. follow-up
5
59
1
75.18994
male
0
16
Coma
Coma
1
11
null
0
28,256
18,162.5
19,583.9688
30
white
19
13
0.716919
0.664917
1
0
0
no
null
0.1
dnr after sadm
2
119
13.298828
82
10
39
217.75
6.299805
0.5
0.799927
129
7.429688
null
null
null
null
3
adl>=4 (>=5 if sur)
3
803
1
59.68198
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
26
27,637
20,644.2188
18,140.7812
12.666664
white
24.898438
30
0.674927
0.580933
8
0
0
no
0.99
0.99
no dnr
16
79
5.799805
104
32
36.29688
182.5
null
null
1.199951
133
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
1,714
0
27.57599
female
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
66,054
44,900.9688
42,967.5625
38.25
white
30.597656
38
0.79895
0.731934
1
0
0
yes
null
null
no dnr
36
114
14.398438
156
8
39.79688
90
2.5
0.799927
0.799927
141
7.419922
null
null
null
null
0
no(M2 and SIP pres)
0
1,713
0
78.17896
male
0
7
Coma
Coma
3
12
$11-$25k
94
8,144
6,759.1758
5,843.91797
7
white
17.597656
30
0.202972
0.142975
1
1
0
yes
0.1
0.001
dnr after sadm
1
160
null
55
10
38.69531
null
4.399414
1.399902
1.099854
136
null
null
null
null
null
1
<2 mo. follow-up
1
13
1
83.71497
male
0
16
COPD
COPD/CHF/Cirrhosis
4
null
null
0
14,147
11,711.2266
11,323.7344
8.666664
white
22.699219
35
0.706909
0.545898
1
0
1
no
0.1
0.001
no dnr
16
113
11
98
32
36.19531
328.5625
3.299805
0.599976
1.599854
145
7.469727
null
null
null
null
null
<2 mo. follow-up
6.245117
24
1
56.87299
female
0
5
Lung Cancer
Cancer
1
13
$11-$25k
0
3,967
3,125.1289
2,416.75977
6
white
13.699219
9
0.782959
0.545898
1
0
0
metastatic
0.9
0.6
no dnr
5
120
null
70
16
37.39844
null
null
null
0.899902
136
null
null
null
null
0
1
no(M2 and SIP pres)
1
339
1
81.23798
male
0
8
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
3,321
2,890.4688
2,371.45898
8
white
25.699219
43
0.712891
0.553955
1
0
0
no
0.9
0.6
dnr after sadm
2
66
6.5
67
26
35.09375
314.25
null
null
3.199707
138
7.389648
null
null
null
1
0
no(M2 and SIP pres)
0
172
1
70.11597
female
0
6
CHF
COPD/CHF/Cirrhosis
3
null
null
0
4,026
3,175.8555
2,303.68945
15
white
18.398438
38
0.863892
0.774902
1
0
0
no
0.3
0.3
dnr after sadm
4
111
6.199219
60
20
36.19531
432
4.199219
3
2.199707
142
7.449219
null
null
null
null
null
null
2.026367
356
1
75.56696
male
0
6
CHF
COPD/CHF/Cirrhosis
2
15
$25-$50k
0
3,858
3,200.0078
2,140.43945
12
white
24.5
35
0.762939
0.623901
1
0
0
no
0.3
0.3
no dnr
6
63
10.099609
62
28
36.19531
null
null
null
1.799805
129
null
null
null
null
0
0
no(M2 and SIP pres)
0
445
1
71.70398
male
0
3
Lung Cancer
Cancer
1
9
$11-$25k
0
2,892
1,818.7529
1,053.38965
20
white
8.5
13
0.831909
0.633911
1
0
0
metastatic
0.9
0.75
no dnr
3
119
4.399414
70
20
36.19531
null
4.099609
0.299988
1.099854
134
null
null
null
null
null
null
no(M2 and SIP pres)
1.763184
382
1
47.836
male
0
8
Lung Cancer
Cancer
1
null
null
0
12,897
9,535.0703
7,931.29688
9
white
18.796875
12
0.711914
0.431946
1
0
0
metastatic
null
null
dnr after sadm
5
65
19.898438
64
24
36.79688
187.75
null
null
null
140
7.459961
null
null
null
null
0
<2 mo. follow-up
0
35
1
80.24896
male
0
5
Lung Cancer
Cancer
2
12
under $11k
26
2,348
2,023.4707
1,745.43945
3
white
19.097656
28
0.501953
0.181
1
0
0
metastatic
0.25
0.05
dnr after sadm
2
68
15.298828
60
24
36.19531
328.5625
null
0.299988
1.299805
133
7.489258
null
null
null
null
0
<2 mo. follow-up
0
54
1
64.61896
male
0
11
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
6,593
5,362.8945
5,065.03906
13.5
white
19.097656
25
0.875
0.792969
1
0
0
no
0.4
0.3
dnr after sadm
1
104
5.199219
114
24
36.39844
230.40625
4.399414
0.699951
0.699951
127
7.289062
null
null
null
0
3
null
3
1,194
1
76.74194
male
0
8
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
7,830
null
null
14
white
23.898438
40
0.615967
0.429993
1
0
0
metastatic
0.75
0.5
dnr after sadm
1
116
12.5
101
28
36.19531
166.65625
null
1.299805
1
140
7.439453
null
null
null
1
5
no(M2 and SIP pres)
5
335
1
68.19397
female
0
9
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
17,719
11,150.5703
13,351.75
18
white
19.398438
36
0.858887
0.766968
1
0
0
no
null
null
no dnr
9
67
14
79
30
38.59375
297.125
3.699707
0.399963
2.799805
137
7.459961
null
null
null
null
1
null
1
582
1
49.74899
male
0
5
Colon Cancer
Cancer
1
14
$25-$50k
0
3,279
2,579.3574
2,068.5293
2
white
9.099609
9
0.91394
0.800903
1
0
0
metastatic
0.8
0.5
no dnr
5
112
18.796875
71
20
36.29688
null
4.199219
0.699951
1
135
null
null
null
null
null
null
no(M2 and SIP pres)
1.530273
941
1
60.63797
male
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
41
49,563
35,439.3438
30,543.0938
18
white
19.898438
19
0.661987
0.564941
7
0
0
yes
null
null
no dnr
40
106
13
70
26
37.39844
null
null
null
0.899902
157
null
null
null
null
null
7
<2 mo. follow-up
7
41
1
75.12097
male
0
3
Coma
Coma
1
10
$11-$25k
100
132,648
96,514.8125
91,364.6875
37
white
27.898438
42
0.014
0.006
49
1
0
no
0
0
dnr after sadm
3
106
15.099609
120
10
35.89844
185.6875
null
null
1.199951
149
7.519531
null
null
null
null
1
<2 mo. follow-up
1
7
1
60.31198
male
0
8
COPD
COPD/CHF/Cirrhosis
3
12
null
0
15,597
11,050.25
11,797.4844
17.5
white
12.199219
10
0.919922
0.863892
1
1
0
yes
null
null
no dnr
8
119
null
80
22
37.89844
236.65625
null
null
null
140
7.40918
null
null
null
0
0
no(M2 and SIP pres)
0
1,698
0
46.16299
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$11-$25k
0
15,063
10,876.1328
9,414.65625
16.666656
white
17.699219
18
0.914917
0.883911
1
1
0
no
0.95
0.95
no dnr
14
72
15.898438
101
24
37.79688
385.6875
2.799805
0.199982
0.699951
138
7.469727
null
null
null
2
0
no(M2 and SIP pres)
0
1,697
0
81.383
male
0
5
COPD
COPD/CHF/Cirrhosis
1
12
null
0
3,057
2,497.6152
2,044.87988
6
white
21.5
47
0.748901
0.60498
1
0
0
no
0.8
0.8
dnr after sadm
1
115
9.5
104
32
36.29688
200
3.699707
0.899902
1.599854
141
7.289062
null
null
null
null
null
no(M2 and SIP pres)
2.524902
1,119
1
64.797
male
0
3
Lung Cancer
Cancer
3
13
$11-$25k
9
17,922
null
null
14
white
26.097656
25
0.438965
0.129974
1
0
0
metastatic
null
null
dnr after sadm
1
85
12.5
74
28
35.59375
216
2.899902
0.399963
1
135
7.519531
null
null
null
null
null
<2 mo. follow-up
2.776367
15
1
60.50699
female
0
10
Cirrhosis
COPD/CHF/Cirrhosis
3
14
$25-$50k
26
4,271
3,857.6211
3,136.87891
3
white
19.597656
23
0.715942
0.557983
1
0
0
no
0.5
0.2
no dnr
10
101
8.199219
98
20
37.59375
null
2.5
4.699219
1.199951
133
null
null
null
null
null
1
no(M2 and SIP pres)
1
1,693
0
74.30499
female
0
12
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
11,889
10,361.5
6,427.02734
7
white
23.699219
51
0.780884
0.649902
1
0
0
no
0.5
0.25
dnr after sadm
7
144
9.5
57
36
35.69531
null
3.399902
0.699951
10.699219
138
null
null
null
null
1
1
no(M2 and SIP pres)
1
95
1
58.58499
male
0
17
Lung Cancer
Cancer
1
10
under $11k
0
19,331
14,248.3594
12,482.1875
1.666666
white
2
14
0.907959
0.787964
1
0
0
metastatic
null
null
no dnr
17
107
5.799805
74
20
36.39844
null
4.699219
0.399963
0.799927
141
null
null
null
null
0
3
no(M2 and SIP pres)
3
137
1
69.63995
male
0
6
Colon Cancer
Cancer
1
12
null
0
2,711
2,272.2207
1,845.94922
9
white
6.299805
14
0.914917
0.80188
1
0
0
metastatic
0.8
0.5
no dnr
6
84
2.599609
69
16
36.59375
null
4.199219
0.299988
0.799927
140
null
null
null
null
null
null
no(M2 and SIP pres)
1.462647
252
1
77.74896
male
0
5
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
3,096
2,368.7988
2,224.23828
12
white
17.898438
30
0.826904
0.717896
1
0
0
no
1
0.9
dnr after sadm
1
107
6.699219
107
36
35.69531
292.25
4.099609
0.699951
1
136
7.399414
null
null
null
null
null
adl>=4 (>=5 if sur)
2.427734
307
1
50.92999
male
0
10
COPD
COPD/CHF/Cirrhosis
4
14
under $11k
0
9,339
7,388.5195
6,231.41797
16
white
16.5
35
0.934937
0.889893
1
1
0
no
0.8
0.7
no dnr
10
63
17.898438
64
26
36.29688
174.4375
5
0.299988
1.299805
133
7.269531
null
null
null
1
1
<2 mo. follow-up
1
30
1
52.797
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
4,438
3,861.0684
2,866.25977
7
white
15.298828
25
0.924927
0.872925
1
0
0
no
0.9
0.9
no dnr
8
69
4.799805
81
24
35.89844
371.375
3.799805
1.299805
1.5
138
7.449219
null
null
null
0
3
no(M2 and SIP pres)
3
1,689
0
31.713
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
$11-$25k
37
10,920
8,458.4609
7,821.01953
17.5
white
26.296875
23
0.793945
0.726929
1
0
0
no
0.95
0.95
no dnr
9
99
13.699219
112
34
38.39844
122
3.899902
0.399963
1.099854
135
7.429688
null
null
null
null
0
no(M2 and SIP pres)
0
1,688
0
69.29199
female
0
12
COPD
COPD/CHF/Cirrhosis
4
6
null
0
13,456
11,271.9844
9,376.40625
29
white
22.597656
43
0.81189
0.694946
1
1
0
no
0.3
0.1
no dnr
12
69
23.097656
74
30
39.29688
135.375
3.799805
0.399963
1.599854
136
7.269531
null
null
null
null
0
no(M2 and SIP pres)
0
136
1
73.52496
female
0
6
Lung Cancer
Cancer
1
15
$11-$25k
0
5,701
3,808.8281
2,135
3
white
15.599609
19
0.715942
0.436951
1
0
0
metastatic
null
null
dnr after sadm
1
76
8.699219
83
16
35.79688
null
null
null
1
140
null
null
null
null
null
null
<2 mo. follow-up
2.038574
52
1
86.29199
female
0
5
Coma
Coma
1
null
under $11k
9
3,476
2,653.5254
3,517.68945
9
white
19.5
34
0.581909
0.515991
1
0
0
no
0.6
0.5
dnr after sadm
1
55
3.899902
66
16
36.29688
409.5
3.899902
0.399963
1.5
137
7.329102
null
null
null
null
null
adl>=4 (>=5 if sur)
1.975342
1,507
1
62.245
female
0
15
Lung Cancer
Cancer
1
12
null
0
15,038
11,057.7109
8,136.77734
5.666664
white
11
7
0.813965
0.600952
1
0
0
metastatic
1
0.9
no dnr
15
83
9.5
56
16
36.29688
383.3125
4.099609
0.399963
0.699951
138
7.389648
null
null
null
0
null
no(M2 and SIP pres)
0.4948
1,685
0
82.461
male
0
9
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
8,452
6,526.9961
5,874.76953
12.5
white
14.099609
32
0.802979
0.681885
1
0
0
metastatic
null
null
dnr after sadm
1
76
14.099609
94
32
38.19531
null
4.099609
0.799927
1.5
140
null
null
null
null
2
null
no(M2 and SIP pres)
1.839
97
1
77.32495
female
0
15
Coma
Coma
2
9
under $11k
9
27,359
19,229.3594
19,049.2344
29
white
35.796875
55
0.20697
0.145996
1
1
0
no
null
null
no dnr
15
68
20.199219
38
8
36
98
3.199707
0.799927
2.099609
132
7.569336
null
null
null
null
0
no(M2 and SIP pres)
0
1,682
0
62.35699
female
0
25
Lung Cancer
Cancer
2
12
under $11k
26
18,644
14,690.625
13,655.9453
8
white
20.199219
14
0.531982
0.208984
1
0
0
metastatic
null
null
dnr after sadm
1
125
6.799805
98
20
36
null
3.799805
0.5
0.5
128
null
null
null
null
0
null
<2 mo. follow-up
0.4948
26
1
63.81897
male
0
12
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
9
11,890
14,882.8672
17,460.9688
7
white
20.898438
35
0.723999
0.569946
1
0
0
no
0.95
0.9
no dnr
12
114
3.599609
77
28
36.39844
395.1875
2.199707
5.099609
1
132
7.439453
null
null
null
null
null
null
3.095703
989
1
84.40198
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
39,436
28,832.125
24,767.2812
17.25
white
28.398438
42
0.509888
0.392944
4
0
0
yes
null
null
no dnr
26
108
13.298828
114
34
38.5
165
2.5
5.799805
1.199951
140
7.399414
null
null
null
null
0
no(M2 and SIP pres)
0
1,680
0
54.83899
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
$25-$50k
26
35,532
25,060.6406
20,688.0156
20
white
23.097656
38
0.735962
0.653931
8
0
0
no
0.9
0.5
no dnr
19
113
0.599976
78
28
38.19531
null
null
null
1.099854
134
null
null
null
null
null
0
no(M2 and SIP pres)
0
608
1
78.00397
male
0
16
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
89
13,530
10,402.1641
9,860.77344
16
white
19.5
42
0.45697
0.254944
1
0
0
no
null
null
dnr after sadm
1
115
6.199219
114
40
36.39844
200
4.299805
0.599976
1.299805
133
7.30957
null
null
null
null
1
no(M2 and SIP pres)
1
1,320
1
80.65399
male
0
17
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
11,279
8,929.6641
8,080.92969
5
white
15.298828
30
0.842896
0.741943
1
0
0
no
0.95
0.7
no dnr
17
117
14.798828
76
32
37.69531
212
3.599609
0.299988
1.099854
136
7.419922
null
null
null
null
4
adl>=4 (>=5 if sur)
4
56
1
61.84799
male
0
10
CHF
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
9,035
7,038.8789
5,574.87891
3
white
21.597656
20
0.853882
0.758911
1
0
0
no
null
null
no dnr
10
117
12
52
20
36.29688
null
null
null
1.799805
142
null
null
null
null
0
0
no(M2 and SIP pres)
0
1,263
1
67.92096
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
7,176
5,485.707
4,777.27734
7.5
white
16.796875
30
0.884888
0.806885
1
0
0
no
0.8
0.7
no dnr
8
115
15.599609
73
28
36.09375
316
3.899902
2.199707
1.099854
138
7.489258
null
null
null
1
2
no(M2 and SIP pres)
2
1,293
1
81.32495
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
17,767
12,111.5
11,936.0938
44
white
22.796875
42
0.765991
0.690918
1
0
1
no
0.5
0.5
no dnr
12
153
14.798828
180
30
37
260
null
0.599976
1.299805
137
7.439453
null
null
null
null
null
null
4.446289
1,082
1
82.034
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
29,147
19,972.7969
18,855.2656
49
white
29.898438
32
0.576904
0.46698
3
0
0
no
null
null
dnr after sadm
7
70
13.298828
104
34
36.89844
108.15625
3
1.899902
0.599976
138
7.40918
null
null
null
null
1
<2 mo. follow-up
1
9
1
18.16299
male
1
13
MOSF w/Malig
ARF/MOSF
2
11
under $11k
0
28,791
19,518.8125
19,102.4688
29
white
36.695313
51
0.395996
0.276978
4
0
0
yes
0.8
0.4
dnr after sadm
4
99
0.399963
162
30
35.59375
null
2.899902
1.099854
0.899902
128
null
null
null
null
null
0
<2 mo. follow-up
0
13
1
62.05099
male
0
8
COPD
COPD/CHF/Cirrhosis
0
8
under $11k
0
5,982
4,658.9492
5,951.04688
11.5
white
19
46
0.885986
0.80896
1
0
0
no
0.75
0.6
no dnr
8
75
5.899414
120
28
36
180.9375
4.399414
0.599976
1.199951
144
7.399414
null
null
null
1
null
no(M2 and SIP pres)
1.1669
1,289
1
71.95898
female
0
10
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
12,002
8,890.0938
8,010.32812
17.5
white
14
16
0.884888
0.806885
2
0
0
no
0.99
0.9
no dnr
10
109
8.5
80
14
36.79688
263.3125
null
null
0.899902
136
7.419922
null
null
null
0
1
no(M2 and SIP pres)
1
1,671
0
73.46198
male
0
9
CHF
COPD/CHF/Cirrhosis
4
8
$11-$25k
0
13,836
9,594.8672
8,788.75781
9
white
17.398438
34
0.86499
0.776978
1
0
0
no
null
null
no dnr
9
121
11
77
24
36.29688
null
4.299805
0.899902
3.299805
137
null
null
null
null
0
0
no(M2 and SIP pres)
0
1,671
0
84.95599
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
12,203
9,469.4922
8,214.61719
12.333328
white
25.898438
40
0.626953
0.523926
1
0
0
yes
0.1
0.001
no dnr
14
67
14
98
14
37.09375
152.5
2.799805
0.299988
0.799927
128
7.489258
null
null
null
null
6
adl>=4 (>=5 if sur)
6
812
1
69.27594
female
0
27
Coma
Coma
0
null
null
44
38,022
26,870.375
26,151.9688
13.5
white
20.699219
26
0.484985
0.412964
4
0
0
no
null
null
no dnr
27
121
10.5
48
12
37.59375
null
3.599609
0.399963
0.799927
132
null
null
null
null
null
null
null
1.786865
1,667
0
60.11499
female
0
6
CHF
COPD/CHF/Cirrhosis
7
9
under $11k
0
4,692
3,511.5918
3,721.19922
15
white
17.199219
16
0.872925
0.789917
1
1
0
yes
0.8
0.5
no dnr
6
67
4.599609
106
24
36.69531
695.625
null
null
1.199951
141
7.379883
null
null
null
2
0
null
0
275
1
71.38397
male
0
11
Lung Cancer
Cancer
3
13
null
0
5,350
4,478.0977
3,933.62891
6
white
15.099609
11
0.72998
0.458984
1
1
0
metastatic
null
0.9
no dnr
11
97
null
64
22
36.39844
null
null
null
null
140
null
null
null
null
null
6
no(M2 and SIP pres)
6
338
1
28.38599
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
null
0
18,497
13,451.375
11,497.1328
16.333328
white
26.5
27
0.87793
0.835938
1
0
0
no
0.99
0.98
no dnr
19
104
13.599609
130
36
38.69531
291.375
3.599609
1.699951
1
129
7.429688
null
null
null
0
0
no(M2 and SIP pres)
0
1,665
0
49.98499
male
0
5
COPD
COPD/CHF/Cirrhosis
5
12
under $11k
0
3,431
2,554.0234
2,946.48828
21
white
19.796875
56
0.917969
0.861938
1
1
0
no
null
null
no dnr
5
77
0
118
28
36.79688
226.0625
null
0.5
1.299805
139
7.339844
null
null
null
0
null
null
0.4948
678
1
76.29797
female
1
42
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
26
120,826
89,628.6875
78,063.5625
45.25
white
38.695313
46
0.145996
0.068985
4
0
0
yes
0.5
0.5
dnr after sadm
25
115
7.5
108
24
36.19531
65.32812
3
1.199951
3.5
128
7.289062
null
null
null
null
1
<2 mo. follow-up
1
42
1
75.15399
female
0
16
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
22,379
null
null
21.666656
white
25.597656
20
0.7229
0.567993
1
0
0
no
0.5
0.4
dnr after sadm
8
113
8.798828
122
8
37.89844
165.6875
2.899902
0.299988
0.699951
137
7.429688
null
null
null
null
4
no(M2 and SIP pres)
4
195
1
84.36395
female
1
5
Coma
Coma
2
null
under $11k
55
13,091
9,422.0234
9,327.80469
30
white
21.398438
32
0.143982
0.092987
9
0
0
yes
null
null
dnr after sadm
1
65
17.398438
68
10
38.09375
134.28125
null
null
0.699951
139
7.329102
null
null
null
null
1
<2 mo. follow-up
1
5
1
64.21899
female
0
5
Lung Cancer
Cancer
2
10
under $11k
0
3,567
2,746.0898
2,405.16992
10
white
12.398438
17
0.789917
0.556885
1
0
0
metastatic
0.8
0.6
no dnr
5
61
10.798828
101
22
36.39844
null
4.099609
0.199982
0.599976
138
null
null
null
null
null
0
no(M2 and SIP pres)
0
470
1
80.10095
female
0
16
Lung Cancer
Cancer
3
14
null
26
9,337
8,238.9609
7,692.53906
6
white
16.398438
28
0.575928
0.254944
1
0
0
metastatic
0.99
0.5
dnr after sadm
9
111
10.298828
69
26
36
null
3.699707
1
1
134
null
null
null
null
null
1
<2 mo. follow-up
1
35
1
72.14197
female
0
10
COPD
COPD/CHF/Cirrhosis
3
null
null
9
14,128
11,301.0312
11,208.1797
20
white
18.898438
48
0.823975
0.712891
1
0
0
no
0.1
0.001
dnr after sadm
1
124
12
67
44
37.59375
132.125
4.099609
0.5
1
142
7.359375
null
null
null
null
null
null
3.59375
1,657
0
70.74298
female
0
4
Colon Cancer
Cancer
1
8
$11-$25k
0
4,544
3,273.3379
2,788.73828
6
white
15.599609
9
0.825928
0.622925
1
0
0
metastatic
1
1
no dnr
4
118
8.5
76
20
36.89844
null
3.399902
1.099854
0.799927
136
null
null
null
null
null
null
<2 mo. follow-up
1.703857
52
1
76.92297
female
0
13
COPD
COPD/CHF/Cirrhosis
0
12
$11-$25k
0
20,151
14,541.9453
14,463.2734
13.5
white
23.398438
26
0.709961
0.549927
4
0
0
no
null
null
no dnr
13
102
9.699219
76
24
36.09375
300
2.799805
0.5
1.199951
128
7.379883
null
null
null
null
3
adl>=4 (>=5 if sur)
3
683
1